WEHI-P8
WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease (PLpro) . It inhibits SARS-CoV-2 PLpro with an IC50 of 12 nM and demonstrates excellent cellular activity with an EC50 of 298 nM. Additionally, WEHI-P8 has protective effects in mice against prolonged lung and brain symptoms caused by SARS-CoV-2. This compound is applicable for research on post-COVID-19 syndrome.
Product Specifications
Field of Research
Infectious Disease & Virology
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
19682121 3x 1.0µg DNA
FAM102B CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details ![Rabbit Polyclonal CX3CR1 Antibody [mFluor Violet 450 SE]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP1-76949MFV450 0.1 mL
Rabbit Polyclonal CX3CR1 Antibody [mFluor Violet 450 SE]
Sign In for Pricing
View Details 